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FLICE-inhibitory protein (FLIP) is an endogenous inhibitor of the signaling pathway triggered by the activation of death receptors. Here,
we reveal a novel biological function for the long form of FLIP (FLIP-L) in neuronal differentiation, which can be dissociated from its
antiapoptotic role. We show that FLIP-L is expressed in different regions of the mouse embryonic nervous system. Immunohistochem-
istry of mouse brain sections at different stages reveals that, in neurons, FLIP is expressed early during the embryonic neuronal devel-
opment (embryonic day 16) and decreases at later stages (postnatal days 5–15), when its expression is essentially detected in glial cells.
FLIP-L overexpression significantly enhances neurotrophin-induced neurite outgrowth in motoneurons, superior cervical ganglion
neurons, and PC12 cells. Conversely, the downregulation of FLIP-L protein levels by specific RNA interference significantly reduces
neurite outgrowth, even in the presence of the appropriate neurotrophin stimulus. Moreover, NGF-dependent activation of two main
intracellular pathways involved in the regulation of neurite outgrowth, extracellular signal-regulated kinases (ERKs) and nuclear factor
B (NF-B), is impaired when endogenous FLIP-L is downregulated, although TrkA remains activated. Finally, we demonstrate that
FLIP-L interacts with TrkA, and not with p75NTR, in an NGF-dependent manner, and endogenous FLIP-L interacts with TrkB in whole-
brain lysates from embryonic day 15 mice embryos. Altogether, we uncover a new role for FLIP-L as an unexpected critical player in
neurotrophin-induced mitogen-activated protein kinase/ERK- and NF-B-mediated control of neurite growth in developing neurons.
Introduction
Neurotrophins, which include nerve growth factor (NGF), brain-
derived neurotrophic factor (BDNF), and neurotrophins 3 and
4/5, are by far the best characterized family of neurotrophic fac-
tors (Lewin and Barde, 1996) and are essential for the develop-
ment of the nervous system. Each neurotrophin can bind to two
different types of receptors: the Trk receptor tyrosine kinase
(TrkA, TrkB, or TrkC) and the p75 neurotrophin receptor
(p75NTR), amember of the tumor necrosis factor receptor super-
family (Dechant and Barde, 2002). In addition to their effects on
neuronal cell survival, neurotrophins also regulate axonal and
dendritic guidance and growth as well as synaptic plasticity
(McAllister, 1999; Chao, 2003). During ligation of neurotro-
phins, Trk and p75NTR receptors activate the mitogen-activated
protein kinase (MAPK)/extracellular signal-regulated kinase
(ERK) and the nuclear factor B (NF-B) pathways, inducing
both neuronal survival and differentiation (Wood, 1995; Yoon et
al., 1998; Hamanoue et al., 1999; Foehr et al., 2000a; Wooten et
al., 2001; Sole et al., 2004).
Recently, we have provided evidence that the differentiation
induced by neurotrophins is controlled by the short isoform of
Fas apoptosis inhibitory molecule (FAIM-S) (Sole et al., 2004).
The long formof the FLICE-inhibitory protein (FLIP-L), another
antagonist of death receptors (DRs), is an endogenous inhibitor
of the Fas-associated death domain (FADD)/caspase-8 proapop-
totic signaling pathway. FLIP-L is a widely expressed molecule
that confers resistance to DR-induced apoptosis in a wide range
of cellular models (Irmler et al., 1997; Thome et al., 1997; Yeh et
al., 2000). Although the antiapoptotic role of FLIP-L is well es-
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tablished in the immune system, its implication as a DR antago-
nist in neurons is not conclusive. FLIP-L serves as a modulator
between apoptotic and proliferative responses in the immune
system (Tseveleki et al., 2004). For instance, in T lymphocytes,
FLIP-L interacts with different adaptor proteins to activate ERK
andNF-B signaling pathways (Kataoka et al., 1998, 2000). Thus,
FLIP-L is a protein with dual roles displaying antiapoptotic or
proliferation/differentiation properties, at least in the im-
mune system. In the nervous system, FLIP-L might control
apoptosis of embryonic motoneurons during development
(Raoul et al., 1999). More recently, it has been reported that
FLIP-L protects neurons against in vivo ischemia and in vitro
glucose deprivation-induced cell death (Taoufik et al., 2007).
Nonetheless, a potential role of FLIP-L in neuronal differen-
tiation has never been addressed.
In the present work, we show that FLIP-L is expressed in dif-
ferent regions of the nervous system, predominantly at the early
embryonic stages. The overexpression of FLIP-L protects mo-
toneurons from apoptosis induced by BDNF deprivation but not
superior cervical ganglion (SCG) neurons nor differentiated
PC12 cells from NGF deprivation. Moreover, in all those neuro-
nal models, the overexpression of FLIP-L markedly increases
neurotrophin-induced neurite outgrowth. Furthermore, the de-
crease of the endogenous levels of FLIP-L significantly reduces
neurite outgrowth, even in the presence of the appropriate neu-
rotrophin stimulus. In PC12 cells, FLIP-L is necessary for the
activation of MAPK/ERK and NF-B signaling pathways after
NGF treatment. However, the knockdown of FLIP-L does not
affect the kinase activity of TrkA.We also substantiate for the first
time that FLIP-L binds the neurotrophin receptor TrkA, but not
p75NTR, during NGF stimulation. Furthermore, endogenous
FLIP-L also binds TrkB in whole-brain lysates from embryonic
day 15 (E15)mice embryos. These findings uncover a new role for
FLIP-L as a crucial factor in neurotrophin-induced control of
neurite growth.
Materials andMethods
Reagents.Allbiochemical reagentswereobtained fromSigma-Aldrichunless
otherwise indicated. Purified recombinant human NGF was obtained from
Genentech. Recombinant humanBDNFwas obtained fromAlomone Labs.
PD98059 (2-amino-3-methoxyflavone)was purchased fromCalbiochem/
Merck Biosciences.
Cell culture. PC12 cells were grown on 100 mm collagen-coated tissue
culture dishes (Falcon Discovery Labware; BD Biosciences) in DMEM
supplemented with 6% heat-inactivated fetal calf serum, 6% heat-
inactivated horse serum (Invitrogen), 10mMHEPES, 20 U/ml penicillin,
and 20 g/ml streptomycin. SCG neurons were isolated as described
previously (Davies et al., 1993). Briefly, they were dissected from postna-
tal day 1 (P1) CD1mice, trypsinized (0.25% trypsin for 25 min at 37°C),
and mechanically dissociated. Neurons were plated in defined, serum-
free medium on a polyornithine/laminin substratum in 35 mm tissue
culture dishes and were incubated at 37.5°C in a humidified 3.5% CO2
incubator for 3–4 h to allow the cells to attach before ballistic transfec-
tion. Spinal cord motoneurons (MTNs) were purified from E12.5 CD1
mice according to Arce et al. (1998) and Comella et al. (1994).
Plasmids. Mouse FLIP-L, rat FAIM-S, human TrkA, p75NTR, and
super-repressor IB (SR-IB) cDNAs were expressed under the con-
trol of a cytomegalovirus constitutive promoter in the pcDNA3 expres-
sion vector (Invitrogen). Enhanced green fluorescent protein (EGFP)
plasmid was obtained from Clontech/BD Biosciences. The NF-B-
dependent reporter vector (B HIV–LTR–Luciferase) (Rodriguez et al.,
1996) was kindly provided by Dr. Ron Hay (University of St. Andrews,
Fife, UK). Hemagglutinin (HA)-tagged TrkA and p75NTR constructs are
from Dr. Jorge Moscat (Centro de Biología Molecular “Severo Ochoa,”
Madrid, Spain). FLIP-L cDNA was purchased from Imagenes. FAIM-S
and FLIP-L cDNAs were tagged with 3xFLAG and subcloned into the
pcDNA3 mammalian expression vector. FLIP-L–FLAG and FAIM-S–
FLAG cDNAswere also subcloned into the pEIGWvector, giving rise to the
lentiviral FLIP-L–FLAG and FAIM-S–FLAG overexpressing constructs.
For RNA interference (RNAi) experiments, constructs were generated
in the pSUPER.retro.puro plasmid (OligoEngine) using specific oligonu-
cleotides formouse and rat FLIP (sequence data available fromGenBank
under accession numbers NM_207653 and NM_001033864, respec-
tively, indicated by capital letter, as follows: RNAi n°1 (R1), forward,
gatccccGAAGGAGATGATGCTCTTCttcaagagaGAAGAGCATCATCT-
CCTTCttttt; reverse, agctaaaaaGAAGGAGATGATGCTCTTCtctcttgaa-
GAAGAGCATCATCTCCTTCggg; or RNAi n°2 (R2), forward,
gatccccCATCCACAGAATAGACTTGttcaagagaCAAGTCTATTCTGT-
GGATGttttt; reverse, agctaaaaaCATCCACAGAATAGACTTGtct-
cttgaaCAAGTCTATTCTGTGGATGggg.
A scrambled sequence (Scr) from RNAi R1 was obtained using the
following oligonucleotides: scrambled, forward, gatccccGCATATGC-
GTACGGATTAGttcaagagaCTAATCCGTACGCATATGCttttt; reverse,
agctaaaaaGCATATGCGTACGGATTAGtctcttgaaCTAATCCGTACGCA-
TATGCggg. Oligonucleotides were obtained from Sigma-Aldrich and
cloned between BglII andHindIII sites of the pSUPER.retro.puro vector,
under the control of the DNA Pol III promoter of H1. pWPTS–EGFP,
pLVTHM, pSPAX2, and pMD2G plasmids were kindly provided by Dr.
Trono (University of Geneva, Geneva, Switzerland). Lentiviral con-
structs were achieved by digestion at the EcoRI–ClaI sites to replace H1
promoter in the lentiviral vector pLVTHM with H1–short hairpin RNA
cassette frompSUPER. The pLVTHMplasmidwas subsequently used for
lentiviral knockdown experiments. The plasmid pEIGWwas constructed
by replacing the EGFP nucleotide sequence between the EF1 promoter
and the woodchuck post-transcriptional regulatory element in pWPTS–
EGFP with the internal ribosomal entry site (IRES)–EGFP cassette
from pIRES2–EGFP (Clontech), as described by Zuliani et al. (2006).
The pEIGW plasmid was subsequently used for lentiviral overexpres-
sion experiments.
Lentiviral production. Lentiviruses were propagated as described pre-
viously (Naldini et al., 1996; Zufferey et al., 1998). Briefly, human em-
bryonic kidney 293T (HEK293T) cells were seeded at a density of 2.5
106 cells in 0.1% gelatin-coated 100 mm dishes. The following day, cells
were transfected with 20g of pLVTHM- or pEIGW-derived constructs,
13 g of pSPAX2, and 7 g of pM2G. The transfection was routinely
performed by the calcium phosphate transfection method (Cullen,
1987). Cells were allowed to produce lentiviruses for 48 h. After 48 h, the
medium was centrifuged at 1200 g for 5 min, and the supernatant was
filtered using 45m filters. Lentiviruses were concentrated at 50,000 g
for 90 min and then resuspended in 20 l of PBS containing 1% BSA.
Lentiviruses were stored at80°C. Biological titers of the viral prepara-
tions expressed as a number of transducing units (TU) permilliliter were
determined by transducing HEK293T cells in limiting dilutions. After
48 h of incubation, the percentage of GFP-positive cells was counted, and
viruses at 5 108 to 1 109 TU/ml were used in the experiments. After
4 h,mediumwas changed and infection efficiency wasmonitored in each
experiment by direct counting of GFP-positive cells. The percentage of
infected cells reached at least 90%.
Cell transfection and infection. Unless infected with lentiviruses, PC12
cells were transfected with the desired plasmid using Lipofectamine2000
reagent (Invitrogen) following the instructions of the manufacturer. Se-
lection of pools of transfected cells was performed by adding G418 to the
culture medium at a final concentration of 500 g/ml.
Ballistic transfectionofSCGneuronal cultureswith theexperimental con-
struct plasmids (pEGFP and pSUPER–scrambled control or pSUPER–FLIP
RNAi R1) was performed as described by Sole et al. (2004).
Motoneurons were transiently transfected using the Lipofectamine2000
reagent. Cells were cotransfected with pEGFP (Clontech/BD Biosciences)
and pSUPER–RNAi R1, pSUPER–RNAi R2, or pSUPER–scrambled,
using a 1:3 molar ratio (pEGFP/desired plasmid) according to the
experimental conditions.
Lentiviral infectionwas performedwhen required, usually to assess the
effects of FLIP-L knockdown by RNAi strategy or to overexpress FLIP-L.
A time course analysis was performed to check the efficiency of both
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overexpression or knockdown of FLIP-L.
FLIP-L levels were assessed by Western blot,
and lentiviruses efficiently induced FLIP-L
protein overexpression or reduced protein lev-
els after 2 and 3 d of infection, respectively, in
all three models.
Neurite measurement. Neurite length and
number of branching points were performed
following the protocol described by Sole et al.
(2004). Transfected EGFP-labeled SCG neu-
rons and MTNs were treated according to the
experimental conditions. After the indicated
time, between 70 and 100 neurons per condi-
tion were visualized and digitally acquired us-
ing an Axioplan Carl Zeiss laser-scanning
confocal microscope. Sholl analysis was per-
formedon SCG images (Sholl, 1953). Bymeans
of especially designed MATLAB script, con-
centric and digitally generated rings 30 m
apart were centered on the cell soma, and the
number of neurites intersecting each ring was
automatically counted as described previously
(Gutierrez and Davies, 2007). Total neurite
length and number of branch points were also
measured. Pairwise comparisons were made us-
ing theStudent’s t test.Formultiple comparisons,
ANOVAwas performed followedby Fisher’s post
hoc test.
Cell death quantification. PC12 cells trans-
fected with the indicated plasmids were
treated with basal medium supplemented
with NGF (100 ng/ml) for 3 d before remov-
ing the neurotrophin. The percentage of ap-
optotic cells showing nuclear condensation
type II after 48 h of deprivation was quanti-
fied using Hoechst staining, as reported pre-
viously (Yuste et al., 2001).
MTNs were counted as described previously
(Pe´rez-García et al., 2004) with some modifi-
cations. Briefly,MTNswere cotransfected after
plating and washed 12 h later, and the differ-
ent experimental conditions were performed for
deprived or BDNF-maintained neurons (10 ng/
ml; Alomone Labs). Neuronal apoptosis is ex-
pressed as the percentage of apoptotic EGFP-
labeled MTNs showing nuclear condensation
type II quantified using Hoechst staining.
SCG neuronal cultures were cotransfected
with the indicated plasmid plus EGFP after
plating and treated or not with NGF (10 ng/
ml). Cell death was quantified as described
above for MTNs.
Western blot. Cells were rinsed with ice-cold
PBS, pH 7.2, and resuspended in prewarmed (95°C) 2% SDS/125 mM
Tris, pH 6.8, lysis buffer. Protein concentrationwas quantified by amod-
ified Lowry assay (DC protein assay; Bio-Rad).
The different cell lysates obtained (5–20 g of protein) were resolved
in SDS-polyacrylamide gels and transferred onto polyvinylidene difluo-
ride (PVDF) Immobilon-P membranes (Millipore Corporation). After
blocking with TBS/0.1% Tween 20 containing 5% nonfat dry milk, the
membranes were probed with the appropriate primary antibodies
against the phosphorylated forms of ERK1 and ERK2, panERK, anti-
IB (Cell Signaling Technology), anti-FLIP (Dave-2) antibody (Alexis
Biochemicals), anti-pan-Trk (-203) generated by our group (according
to Martin-Zanca et al., 1989), anti-rat TrkA, anti-TrkB, anti-phospho-
Tyr (4G10) (Millipore Corporation), anti-HA (clone 3F10; Roche), or
anti -tubulin (clone B-5-1-2) (Sigma).
After incubation with specific peroxidase-conjugated secondary anti-
bodies, the membranes were developed with the EZ-ECL chemilumines-
cence detection kit (Biological Industries) or SuperSignal (Pierce/Thermo
Fisher Scientific).
Immunohistochemistry. E16, P5, P15, and adult OF-1 mice (Charles
River) were used for the immunohistochemistry experiments. First, the an-
imals were deeply anesthetized with a mixture of Ketolar (Parke-Davies/
Pfizer)/Rompun (Bayer) and perfused with 4% paraformaldehyde. The
brains were dissected, cryoprotected, and frozen. Coronal sections of 30–50
m were obtained. Sections were incubated overnight with specific rabbit
antibody against FLIP (1:500; SantaCruzBiotechnology). Primary antibody
was visualized by sequential incubation with biotinylated secondary anti-
bodies (1:200; Vector Laboratories) and the streptavidin–peroxidase com-
plex (1:400; GE Healthcare). Peroxidase was developed with 0.05%
diaminobenzidine and H2O2. The sections were mounted onto gelatinized
slides, dehydrated, and coverslipped with DPX.
Sections from E16 embryos were used for double-immunofluorescence
studies. After blocking, sections were incubated overnight with rabbit
Figure 1. FLIP-L is expressed in the nervous system and is upregulated during neuronal differentiation in vivo and in vitro.
A, Embryonic (E16) and adult (Ad) mouse tissue lysates (20g) were analyzed by SDS-PAGE/immunoblot using anti-FLIP Dave-2
antibody (Alexis Biochemicals) (top). SC, Spinal cord; Cb, cerebellum; Cx, Cortex; Ht, heart; Lv, liver; Kd, kidney. B, Cortical brain
lysates ofmice at different embryonic andpostnatal stageswereprocessed, and FLIP-L immunoblotwasperformed.C, Time course
of FLIP-L protein expression in PC12 cells subjected to NGF-induced differentiation. For loading control, the membranes were
stained with Naphtol Blue (NB). D, After serum deprivation during 12 h, PC12 cells pretreated or not with 50M PD98059 were
treatedwith NGF for 5min (bottom) or 1 and 2 d (top and bottom). Total protein extractswere analyzed byWestern blotting using
an anti-phospho-ERK1/2 antibody (bottom) or an anti-FLIP (Dave-2) antibody for detection of FLIP-L upregulation after NGF
treatment (top). Note that FLIP-L was not upregulated after 1 d of NGF treatment when cells were cultured in the presence of
PD98059 (top). Membranes were stripped and reprobed with an anti-pan-ERK antibody to control protein loading.
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antibody detecting FLIP (1:500; Santa Cruz Biotechnology) combined
withmousemonoclonal antibody against neuronal-specific nuclear pro-
tein (NeuN) (1:100; Millipore Bioscience Research Reagents) or GFAP
(1:500; Millipore Corporation). Primary antibodies were visualized
using secondary Alexa Fluor-conjugated antibodies. Sections were
mounted and viewed under confocal microscopy.
Coimmunoprecipitation experiments. For coimmunoprecipitation ex-
periments, a total of 5 106 PC12 cells or 3 106 HEK293T cells stably
or transiently transfected, respectively, with human TrkA, were plated in
100mm tissue culture dishes and infected with
lentiviral particles containing the pEIGW–
FLIP-L–FLAG, pEIGW–FAIM-S–FLAG or the
empty vector. When indicated, HA-tagged
TrkA or p75NTR were transfected in HEK293T
cells using the calcium phosphate method. At
24 h after infection, cells were serum starved
for 12 h and stimulated or not with 100 ng/ml
NGF for 15min. Cellular lysates were obtained
using immunoprecipitation (IP) lysis buffer
[20 mM Tris, pH 7.4, 140 mM NaCl, 10% glyc-
erol, 1 mM sodium orthovanadate, 25mMNaF,
40 mM -glycerophosphate, 1% NP-40, and
1 EDTA-free Complete protease inhibitor
cocktail (Roche)]. All lysates were quantified
by a modified Lowry assay (DC protein assay;
Bio-Rad). For FLAG immunoprecipitation ex-
periments, 1 mg of total protein was taken and
adjusted with the IP lysis buffer to achieve a
final concentration of 1 g/l. Next, 1 mg of
lysates were subjected to immunoprecipitation
using 40 l of FLAG-specific monoclonal
(mAb) M2-coupled agarose beads (Sigma)
overnight at 4°C in an orbital shaker. Then,
beads were washed five times with IP lysis
buffer and eluted for 30 min at 4°C with 50 l
of TBS containing 150 ng/ml of 3xFLAG com-
petitor peptide (Sigma). After a short spin, su-
pernatants were carefully taken, Laemmli’s
loading buffer was added, and SDS-PAGE was
performed.
For the assessment of TrkA activation, 250
g of protein were immunoprecipitated using
the anti-pan-Trk (-203). Immunocomplexes
were collected with protein A-Sepharose by or-
bital incubation for 1 h and were washed three
times with IP lysis buffer. Beads were sus-
pended in 40 l of Laemli’s loading buffer and
boiled, and samples were loaded onto an 8%
SDS-polyacrylamide gel. Finally, the mem-
brane was blotted with the anti-phospho-Tyr
4G10 antibody.
For the endogenous interaction of FLIP-L
with TrkB in whole-brain lysates, total brain
was obtained from E15 Swiss Webster em-
bryos. Brain was minced in small pieces and
homogenized in IP lysis buffer using a Polytron
homogenizer. Cellular lysates as well as brain
extracts were cleared by centrifugation at
16,000 g and quantified by amodified Lowry
assay (DC protein assay; Bio-Rad). Two milli-
grams of total protein were incubated with 5
g of anti-FLIP (Dave-2) antibody overnight
at 4°C. As a control, a rat monoclonal antibody
anti-HA (rat IgG) was used under the same
conditions. Immunocomplexes were collected
with protein G-Sepharose by orbital shaking
for 1 h and washed three times with IP lysis
buffer. Beads were suspended in 40 l of Lae-
mli’s loading buffer and boiled, and samples
were loaded onto an 8% SDS-polyacrylamide
gel. As input controls, 25–50g of the lysates were blottedwith anti-FLIP
(Dave-2), anti-TrkA, anti-TrkB, anti-HA (clone 3F10), or anti-FLAG
antibodies, as indicated.
NF-B activity. PC12 cells were infected with lentiviral particles con-
taining the sequence encoding for the RNAi R1 against FLIP or its scram-
bled sequence (Scr). After 2 d, cells were seeded in the adequate plates and
transfected with an NF-B-dependent reporter vector (LTR KB). After
24 h, cells were serum starved for 12 h and stimulated with 100 ng/ml
Figure 2. Distribution of FLIP-immunoreactive cells during the development of mice brain. A–C, In the cerebral cortex,
many cells show immunohistochemical labeling. A, E16 neurons contain FLIP in the cortical plate (CP) and subplate (SP).
B, At P5, some neurons in layers II–III present weak immunostaining (arrows); in contrast, at this age, some cells located
throughout all cortical layers are FLIP immunopositive (arrowheads). C, At P15, FLIP-positive cells present in all cortical
layers show an astrocytic morphology. D–F, In the cerebellum, the soma of some Purkinje cells shows immunohistochem-
ical staining at embryonic (arrows in D) and early postnatal mice (arrows in E). At later postnatal stages, cells located just
under the Purkinje cell layer and scattered in the granule cell layer show FLIP immunostaining (F ). G–I, Immunofluores-
cence colocalization (arrows) of FLIP and NeuN (specific neuronal marker) in cortical plate at E16. J–L, Double immuno-
staining with antibodies detecting FLIP and GFAP in cerebral cortex at P15 showed the expression of FLIP in some GFAP-
positive astrocytes (arrows). MZ, Marginal zone; IZ, intermediate zone; VZ, ventricular zone; ML, molecular layer; PCL,
Purkinje cell layer; GL, granule cell layer. Scale bars: (in C) B–F, 100m; (in J), G–L, 50m.
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NGF for the indicated time. Cell lysates were obtained following the
instructions of themanufacturer (Luciferase Assay System kit; Promega)
and as described by Gozzelino et al. (2008).
Statistical analysis. All the experiments were repeated at least three
times. Values were expressed asmean SEM. Student’s t test was used to
determine the statistical significance of differences in neurite length,
branching points numbers, and luciferase activity ( p 0.05 was consid-
ered significant). For multiple comparisons, ANOVA was performed
followed by Fisher’s post hoc test.
Results
FLIP-L is expressed in the nervous system and is upregulated
during neuronal differentiation
To determine whether FLIP isoforms are present in the nervous
system, we analyzed the protein expression profile in different
mouse tissues at both embryonic (E16) and adult stages. An im-
munoreactive band of 55 kDa corresponding to FLIP-L was de-
tected in lysates from different brain regions such as spinal cord,
cerebellum, and cortex, as well as in heart, liver, and kidney (Fig.
1A). The short isoform of FLIP of 25 kDa was not detected in the
nervous system tissues, whereas it was expressed in the non-
neuronal tissues (data not shown). To study whether FLIP-L is
regulated during the development of the nervous system, we per-
formed immunoblots of cortical tissue lysates of mouse brain at
different stages. FLIP-L levels were low at E12.5 when compared
with the peak of expression that was detected at E16. Subse-
quently, FLIP-L levels decreased during the early postnatal stages
and stabilized in the adult (Fig. 1B). To determine whether
FLIP-L expression is regulated during the differentiation process
induced by neurotrophic factors, we used PC12 cells cultured in
the presence of NGF. As shown in Figure 1C, NGF induced an
increase in FLIP-L after 1 d of stimulation compared with the
levels of unstimulated cells. Then, FLIP-L protein amounts de-
creased gradually after 3, 5, and 7 d of neurotrophin stimulation
(Fig. 1C). The NGF-induced upregulation of FLIP-L is depen-
dent on the MAPK/ERK pathway activation, because it can be
prevented when cells are cultured in the presence of the MAP
kinase kinase (MEK) inhibitor PD98059 (Fig. 1D, top). The effi-
ciency of PD98059 for inhibiting MAPK/ERK pathway is sup-
ported by the analysis of the phosphorylation status of ERK1/2 by
Western blot. As shown in the bottom of Figure 1D, PD98059
inhibits ERK1/2 phosphorylation at both acute NGF stimulation
time (5 min) and longer time periods such as 1 and 2 d.
To characterize the expression pattern of FLIP during the de-
velopment of the CNS, we performed immunohistochemistry
using the FLIP-specific antibody. FLIP-labeled cells were de-
tected inmost brain regions throughout development (Fig. 2). In
the embryonic cerebral cortex, labeled cells were located in the
cortical plate and in the subplate, corresponding to postmitotic
neurons in these layers (Fig. 2A). At P5, the cell bodies of layers
II–III cortical neurons exhibited weak FLIP immunostaining
(Fig. 2B). In addition, some cells located throughout all cortical
layers, corresponding to GFAP-immunoreactive glial cells, were
FLIP immunopositive (Fig. 2B, arrowheads, J–L, arrows). At
postnatal and adult stages, the expression of FLIP appeared to be
restricted to glial-like cells in the cerebral cortex (Fig. 2C). The
cerebellum also shows an intense FLIP immunolabeling. FLIP
was expressed in migratory Purkinje cells in the embryonic cere-
bellum (E16) (Fig. 2D). At early postnatal stages (P5), the cell
bodies of Purkinje neurons occupying the incipient Purkinje cell
layer expressed FLIP (Fig. 2E). In addition, at P15 and in adult
mice, some aligned glial cells, GFAP positive, located just under
the Purkinje cell layer, and scattered in the granule cell layer, were
positive for FLIP immunostaining (Fig. 2F) (supplemental Fig. 1,
available at www.jneurosci.org as supplemental material). To
confirm that FLIP was expressed in neurons at embryonic stages,
sections from E16 mice that were double immunolabeled with
FLIP antibodies and the neuronal marker NeuN showed an al-
most complete colocalization of both markers (Fig. 2G–I).
Therefore, we conclude that FLIP is predominantly expressed in
developing neurons during the embryonic and early postnatal
stages of the CNS. Later FLIP is mainly expressed in GFAP-
immunoreactive glial cells (Fig. 2 J–L). The specificity of the an-
tibody used for FLIP immunohistochemistry was validated in the
SCGs that were cotransfected with the pEGFP plasmid and the
overexpression FLIP-L plasmid or a plasmid containing an RNAi
targeting FLIP-L (supplemental Fig. 2A,B, available at www.
jneurosci.org as supplemental material). Indeed, this FLIP anti-
body was able to detect FLIP-L overexpression as well as its
knockdown compared with nontransfected control neurons ex-
pressing endogenous FLIP. Moreover, we ensured that the varia-
Figure 3. A, CulturedmouseMTNswere transfected using Lipofectamine2000with an EGFP
expression plasmid together with pcDNA3 or pcDNA3–FLIP-L (FLIP-L) vectors. Cells were
treated with 10 ng/ml BNDF () or basal medium () for 24 h. Percentage of apoptotic
EGFP-labeled MTNs showing nuclear condensation type II was quantified using Hoechst stain-
ing. B, Ballistic transfections of cultured mouse SCG neurons with an EGFP expression plasmid
togetherwith thepcDNA3 control vector (pcDNA3), pcDNA3–FLIP-L (FLIP-L), or pcDNA3–Bcl-xL
(Bcl-xL) plasmids were performed. After 24 h of incubation with 10 ng/ml NGF () or basal
medium (), percentage of apoptotic EGFP-labeled SCGs was quantified. C, PC12 cells stably
transfected with pcDNA3, Bcl-xL or FLIP-L were treated with basal medium without serum
supplemented with 100 ng/ml NGF for 3 d before trophic factor deprivation. Percentage of
apoptotic cells showing type II nuclear condensation after 48 h of NGF deprivation was quanti-
fied. Significant differences are indicated (*p 0.001, t test). Right, Total lysates were ob-
tained and analyzed by Western blot to assess FLIP-L levels in PC12 stably transfected using
anti-FLIP (Dave-2). The membrane was reblotted with anti-tubulin as a loading control.
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tions in FLIP immunolabeling did not constitute an artifact because
of the cotransfection of FLIP-L or its RNAi togetherwith the pEGFP
plasmid (supplemental Fig. 2C, available at www.jneurosci.org as
supplemental material).
FLIP-L protects motoneurons, but neither differentiated
PC12 cells nor SCG neurons, from cell death induced by
neurotrophin deprivation
To determine whether FLIP-L exerts a protective role against
apoptosis induced by neurotrophin deprivation, we used three
different neuronal models that require neurotrophin support for
in vitro survival. Differentiated PC12 cells and SCGneurons need
NGF, whereas motoneurons are dependent on the presence of
BDNF in the culture media. NGF or BDNF withdrawal leads to
cell death in SCG and PC12 or motoneurons, respectively. Once
confirmed that FLIP-L is normally expressed in these cells (data
not shown), we wanted to ascertain the relevance of this anti-
apoptotic protein in preventing neurotrophin deprivation-
induced cell death. First, we performed survival experiments in
motoneurons overexpressing FLIP-L. To this end, motoneurons
were transiently transfected with pEGFP and either FLIP-L or the
empty pcDNA3 vector and grown in the presence of BDNF or
basal medium (Fig. 3A). Because of the partial transfection effi-
ciency (30%), only EGFP-positive transfected cells are consid-
ered. The percentage of apoptotic motoneurons was calculated
24 h later by nuclear Hoechst staining. FLIP-L-transfected mo-
toneurons treated with basal medium showed a significant pro-
tection from apoptosis compared with
empty vector-transfected neurons (Fig.
3A). Apoptosis observed in FLIP-L-
transfected neurons treated with basal
medium did not significantly differ from
that observed in BDNF-treated neurons
(Fig. 3A).
Subsequently, we performed similar
experiments with the NGF-dependent
neuronal models. SCG neurons were
transiently transfected with an EGFP ex-
pression plasmid together with the
pcDNA3 control vector, FLIP-L, or Bcl-xL
plasmids (Fig. 3B). Bcl-xL was used as an
already established antiapoptotic protein
controlling mitochondrial-driven neuro-
nal cell death during NGF withdrawal
(Lindenboim et al., 1998; Putcha et al.,
2002). After 24 h of incubation with NGF
(10 ng/ml), cells were maintained with
NGF or with basalmedium, and the num-
ber of apoptotic EGFP-labeled neurons
was counted 24 h later (Fig. 3B). NGF-
deprived, FLIP-L-transfected SCG neu-
rons showed a marked decrease in cell
survival similar to that observed in NGF-
deprived empty vector-transfected neu-
rons, whereas Bcl-xL overexpression was
able to protect SCGs from apoptosis in-
duced byNGF deprivation (Fig. 3B). Sim-
ilar resultswere obtainedusing PC12 cells,
our third neuronal model (Fig. 3C). PC12
cells stably transfected with FLIP-L, Bcl-
xL, or the empty vector were grown in the
presence of NGF for 3 d and then NGF
deprived for 48 h. Neurons displaying
type II chromatin condensation were visualized by nuclear
Hoechst staining and quantified. Percentage of cell death in-
creased to 45% in both empty vector- and FLIP-L-transfected
PC12 cells deprived of NGF (Fig. 3C). As found in SCGs cultures,
PC12 cells transfected with Bcl-xL survived NGF deprivation
compared with pcDNA3-transfected cells (Fig. 3B,C). These re-
sults demonstrate that, whereas FLIP-L has an important role in
prevention of cell death after BDNFdeprivation ofmotoneurons,
it is unable to prevent apoptosis after NGF withdrawal in both
differentiated PC12 cells and SCG neurons. Moreover, our re-
sults with the overexpression of Bcl-xL suggest that apoptosis
induced by trophic factor deprivation in NGF-dependent neu-
rons is driven through themitochondrial-dependent pathway, as
reported previously (Lindenboimet al., 1998; Putcha et al., 2002).
FLIP-L overexpression increases neurotrophin-induced
neurite outgrowth in motoneurons, sympathetic neurons,
and PC12 cells
Despite the absence of a general antiapoptotic role in neurotro-
phin deprivation-induced cell death, we noticed that cells trans-
fected with FLIP-L and maintained in the presence of NGF or
BNDF displayed a marked increase in neurite outgrowth com-
pared with empty vector-transfected neurons. Therefore, we de-
cided to further investigate whether FLIP-L overexpression
might have a role in the regulation of neurite outgrowth. Primary
cultures of motoneurons overexpressing FLIP-L showed a marked
increase in neurite outgrowth compared with the empty vector-
Figure 4. A, CulturedmouseMTNswere transfectedwith an EGFP expression plasmid together with the control vector pcDNA3
(Ctrl) or pcDNA3–FLIP-L (FLIP-L) vectors. After 48 h of incubation with Neurobasal medium alone (NF) or supplemented with 10
ng/ml BDNF (BDNF), images were acquired and analyzed. Representativemicrographs (scale bars, 100m) and quantification of
neurite outgrowth are shown. Significant differences are indicated (*p 0.001, t test). B, Ballistic transfections of cultured SCG
neuronswith an EGFP expressionplasmid togetherwith the control vector pcDNA3 (Ctrl) or pcDNA3–FLIP-L (FLIP-L) plasmidswere
performed3hafter plating.After 24hof incubationornotwith10ng/mlNGF (NGF), EGFP-labeledSCGwerevisualizedanddigitally
acquired. Representativemicrographs depict the increased neurite arbor size and complexity (FLIP-L vs Ctrl), and quantification of
neurite outgrowth is presented. Scale bars, 50m. Significant differences are indicated (*p 0.001, ANOVA test).
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transfected cells (Fig. 4A). In addition, FLIP-L-transfected SCG
neurons showed a significant increase in the neurite arbor when
compared with empty vector-transfected neurons (Fig. 4B).
Moreover, PC12 cells stably transfected with FLIP-L also dis-
played a significant increase in neurite outgrowth in the presence
of NGF for 3 d when compared with pcDNA3-transfected cells
(708.00 55.24 vs 156.92 14.14mfor control cells) (Fig. 5A).
To assess the relevance of the MAPK/ERK and NF-B path-
ways in FLIP-L-induced neurite outgrowth, total neurite length
was measured in PC12 cells stably transfected with empty vector
pcDNA3 (Neo) or pcDNA3 encoding for SR-IB, a form of
IB carrying serine-to-alanine mutations at residues 32 and 36
(Fig. 5B). These mutations prevent IB phosphorylation and
subsequent proteasome-mediated degradation, thereby impair-
ing release and nuclear translocation of NF-B (Rodriguez et al.,
1996). Stable PC12 cells were subsequently infected with lentivi-
ral particles either empty (Ctrl) or containing FLIP-L (FLIP-L)
(Fig. 5C). Two days later, cells were serum deprived, then left
untreated (no NGF), or treated with 100 ng/ml NGF for 1 d. The
increase in neurite outgrowth induced by NGF stimulation of
FLIP-L-overexpressing PC12 cells is significantly inhibited dur-
ing blockade of the MAPK/ERK pathway by the MEK inhibitor
PD98059 (Fig. 5C). In contrast, after 1 d of NGF stimulation,
the total neurite length significantly decreases in SR-IB-
overexpressing cells, even when FLIP-L is overexpressed (Fig.
5C). The expression of the dominant-negative forms of IB ki-
nase  (IKK) (pcDNA3–IKK-DN) or IKK (pcDNA3–IKK-
DN) also provokes a reduction in neurite length compared with
pcDNA3-transfected cells (data not shown). However, this im-
pairment in neurite outgrowth attributable to the overexpression
of the SR-IB alone or the MEK inhibitor alone in FLIP-L-
overexpressing cells remains partial. Interestingly, neurite out-
growth is completely abrogated when either control (Ctrl) or
FLIP-L PC12 cells stably expressing SR-IB are additionally
treatedwith theMEK inhibitor PD98059 (Fig. 5C). Together, our
results point out that FLIP-L overexpression is able to promote
neurotrophin-induced neurite outgrowth in all three neuronal
cultures tested (Figs. 4, 5). This novel function of FLIP-L is me-
diated by the activation of both NF-B and MAPK/ERK path-
ways and is independent of its classical role as an inhibitor of the
extrinsic apoptotic pathway.
Endogenous FLIP-L knockdown impairs
neurotrophin-induced differentiation
We wanted to establish the role of endogenous FLIP-L in the
regulation of the neurotrophin-mediated neurite outgrowth pro-
cess. Mouse motoneurons were transfected with EGFP alone or
along with FLIP-L RNAi-encoding vector R1, R2, or the scram-
bled sequence andwere cultured in the presence of BDNF for 3 d.
Efficiency of FLIP-L knockdown in these neurons was confirmed
by Western blot (Fig. 6B). Neuron images were captured using
epifluorescencemicroscopy (Fig. 6A), and the neurite length was
measured by tracing neurite arbors (Fig. 6C). Motoneurons
transfected with FLIP-L RNAi R1, R2, or a combination of both
RNAi (R1R2) displayed a dramatic threefold decrease in neu-
rite length (Fig. 6A,C). However, cell survival in complete me-
dium was not affected by FLIP-L-specific knockdown (data not
shown). Alternatively, knockdown of FLIP-L inmouse SCG neu-
rons, in the presence of NGF, showed nearly a 50% reduction in
both neurite length (695.60 26.41 vs 1162.26 52.83 m for
control cells) and branching point measurements (2.79 0.19 vs
5.13  0.30 for control cells) (Fig. 6D). Likewise, Sholl analysis
that provides a graphic representation of neurite branching with
distance from the cell body evidenced a marked decrease in the
number of neurite intersections in FLIP-L RNAi R1-transfected
SCG neurons when compared with scrambled RNAi-transfected
neurons (Fig. 6E). Comparable results were obtained with undif-
ferentiated PC12 cells infected with FLIP-L RNAi or scrambled
(Scr) lentiviral particles. FLIP-L RNAi is able to reduce the en-
dogenous FLIP-L protein levels in these cultures (Fig. 7A). Figure
7, B and C, shows quantification and representative micrographs
of the decrease in neurite length observed in NGF-treated PC12
cells knocked down for FLIP-L when compared with the control.
The effective reduction of FLIP-L levels gives rise to almost three-
fold reduction in neurite outgrowth after 5 d of NGF treatment
(Fig. 7B). Reduction of FLIP-L endogenous levels does not im-
pede NGF-induced survival or cell cycle arrest (data not shown).
These results point out that NGF-mediated survival and cell cycle
arrest are FLIP-L-independent processes and,more interestingly,
that endogenous FLIP-L expression is required for neurite out-
growth induced by neurotrophic factors in PC12 cells, SCG neu-
rons, and motoneurons.
FLIP-L regulates both ERK and NF-B activation induced
by NGF
Having ascertained the role of FLIP-L in neurite formation in
different neuronal types, we pursued the dissection of the signal-
Figure 5. A, Phase-contrast micrographs of PC12 stably transfected with pcDNA3 empty
vector (Control, top row) or pcDNA3–FLIP-L (FLIP, bottom row). PC12 cells were treated with
completemedium (Serum, left column) orwith NGF 100 ng/ml (right column) for 3 d. Scale bar,
100m. B, PC12 cells stably transfected with empty vector (Neo) or with SR-IB. Total cell
lysateswere analyzed byWestern blot using an antibody against IB (top).Membraneswere
reprobedwith anti-tubulin to normalize the loading content per lane (bottom). C, Stable Neo or
SR-IB PC12 cells were infected with lentiviral particles either empty (Ctrl) or containing
FLIP-L (FLIP-L). Two days later, cells were serum deprived, then left untreated (no NGF) or
pretreated or notwith 50M PD98059, and stimulatedwith 100 ng/ml NGF for 1 d, afterwhich
total neurite length was measured. Significant differences (NGFPD98059-treated vs NGF-
treated; Ctrl or FLIP-L Neo-transfected cells) are indicated (*p 0.001, t test).
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ing pathways involved in this process. TheMAPK/ERK cascade is
considered as one of the main intracellular pathway mediating
neurite outgrowth induced by the activation of neurotrophin
receptors, such as TrkA, TrkB, TrkC, and p75NTR (Encinas et al.,
1999; Chao, 2003). To determine whether FLIP-L affected the
differentiation signaling pathway induced byNGF stimulation of
its receptor, we assessed the levels of both TrkA and ERK1/2
activation in PC12 cells after FLIP-L knockdown in a time course
of NGF stimulation. PC12 cells infected with Scr or FLIP-L
RNAi for 3 d were subjected to serum starvation for 12 h and
then stimulated for the indicated times with NGF (Fig. 7D). To
explore whether FLIP-L affects NGF-induced TrkA activation,
TrkA was immunoprecipitated and immunocomplexes were
blotted using an anti-phospho-tyrosine antibody. The knock-
down of FLIP-L did not affect the activation of TrkA by tyrosine
phosphorylation, which is clearly visible after 5min ofNGF stim-
ulation. Lysates from the same experiment were analyzed by
Western blot to assess the phosphorylation of ERK1/2. In scram-
bled RNAi-infected PC12 cells, ERK1/2
phosphorylation peaks after 5 min of NGF
stimulation then progressively decreases
over time. However, FLIP-L RNAi-infected
PC12 cells exhibit a marked impairment in
NGF-induced ERK phosphorylation com-
pared with scrambled RNAi-infected cells
(Fig. 7D). To determine whether endoge-
nous FLIP-L is involved inNGF-mediated
NF-B activation, the other main path-
way involved in neurotrophin-dependent
neuritogenic process (Sole et al., 2004),
PC12 cells were infected with lentiviral
particles carrying FLIP-L RNAi R1 or its
scrambled control and incubated for 2 d
for an effective knockdown. Then, cells
were transiently transfected with an NF-
B-dependent luciferase reporter con-
struct. At 24 h later, cells were stimulated
for 5 hwith 100 ng/mlNGF, and luciferase
activity was measured as described inMa-
terial and Methods. As shown in Figure
7E, FLIP-L RNAi diminishes NGF-
induced luciferase activity near to its basal
levels, indicating that FLIP-L is amediator
of NF-B activation. Altogether, these re-
sults show that FLIP-L does not affect the
activation of TrkA and confirm the im-
portance of endogenous FLIP-L in the ac-
tivation of both the MAPK/ERK and the
NF-B pathways after NGF-induced neu-
rite outgrowth.
FLIP-L interacts with TrkA in an
NGF-dependent manner
Finally, we seek out at which level FLIP-L
is acting, upstream ERK and NF-B acti-
vation. FLIP-L is a well documented DR
antagonist that prevents cell death by
binding to the adaptor FADD at the death
inducing signaling complex (DISC) level
by the so-called death effector domains
present in both FADD and FLIP-L (Yu et
al., 2008). Conversely, the MAPK/ERK
and NF-B pathways that are engaged by
NGF require the activation of both TrkA and p75NTR, respec-
tively (Chao, 2003). Taking all this into consideration, it would be
likely that an interaction exists between FLIP-L and TrkA,
p75NTR, or even both receptors. We have demonstrated recently
that FAIM-S, a death receptor antagonist that also promotes
NGF-induced neurite outgrowth, interacts with both TrkA and
p75NTR after NGF stimulation (Sole et al., 2004). To determine
whether the same scenario applies for FLIP-L, we used HEK293T
cells transfected with the NGF receptors TrkA or p75NTR, both
tagged with HA, together with FLAG-tagged FLIP-L or FAIM-S.
After 2 d of transfection and 15min of NGF treatment, cells were
lysed and FLAG immunoprecipitation was performed. Figure 8A
demonstrates that, unlike FAIM-S, FLIP-L specifically interacts
with TrkA but not with p75NTR during NGF stimulation. Fur-
thermore, to validate these results in a neuronal model, PC12
cells stably transfected with TrkA were infected with lentiviral
particles containing FLAG-tagged FLIP-L. After 24 h of infection,
cells were stimulated or not with NGF for 15 min and then were
Figure 6. A, Mouse motoneurons were cotransfected with EGFP and pSUPER.retro.puro vector either empty (Ctrl) or with
different RNAi against FLIP-L (R1 or R2) or a scrambled sequence (Scr). Cells were maintained in BDNF-supplemented Neurobasal
medium for 4 d. Micrographs showing representative GFP-labeled motoneurons proved that these cells express the RNAi tran-
script. Scale bars, 50m. B, Total lysates were obtained and analyzed byWestern blot to check for FLIP-L levels using anti-FLIP-L
and then the membrane was stained with Naphtol Blue (NB) as a loading control. C, Quantification of the neurite outgrowth
performed by tracing neurite arbors and measuring neurite length. Differences are significant between scrambled and RNAi-
transfected neurons (*p 0.001, t test). D, Mouse SCG neurons were cotransfected with EGFP and the pSUPER.retro.puro vector
with either RNAi R1 against FLIP-L (R1) or the scrambled RNAi sequence (Scr). At 3 d after transfection, EGFP-labeled SCG were
visualizedanddigitally acquired. Representative imagesofNGF-maintainedSCGsafter FLIP-L knockdownare shown. Scalebars, 50
m. E, Measure of the number of intersections between each neurite and virtual concentric circles from soma to the growth cone.
Significant differences are indicated (*p 0.05, **p 0.001, t test).
Moubarak et al. • FLIP-L Is Necessary for Neuritogenesis J. Neurosci., April 28, 2010 • 30(17):6094–6105 • 6101
lysed, and Trk immunoprecipitation was
performed using a pan-Trk antibody (Fig.
8B). Although lysates from cells cultured
in the absence of NGF failed to show any
interaction, TrkA coimmunoprecipitates
with FLIP-L only during neurotrophin
stimulation, indicating an NGF-dependent
interaction between FLIP-L and TrkA. This
result was confirmed by the reverse coim-
munoprecipitation to consolidate the
interaction between FLIP-L and TrkA.
FLAG-tagged FLIP-L was immunopre-
cipitated from lysates of PC12 cells stably
transfected with TrkA, infected with len-
tiviral particles containing FLIP-L or
empty-vector, and stimulated or not with
NGF for 15min (Fig. 8C). Oncemore, the
interaction of TrkAwith FLIP-L proved to
be NGF dependent. Finally, we demon-
strated that endogenous FLIP-L interacted
with BDNF receptor TrkB in embryonic
mice whole-brain lysates (E15) (Fig. 8D).
Altogether, these results demonstrate for
the first time that, in the nervous system,
FLIP-L possesses a novel function distinct
from its classical antiapoptotic role,medi-
ated by its interaction with the TrkA and
TrkB neurotrophin receptors that do not
belong to the death receptor family. After
NGF-dependent FLIP-L interaction with
TrkA, the MAPK/ERK and NF-B path-
ways are activated, thereby promoting
neurite growth.
Discussion
In the present work, we uncover the role
of FLIP-L in neurotrophin-mediated neu-
rite outgrowth in diverse neuronal mod-
els, which is independent of its classical
antiapoptotic function. Although the rel-
evance of the antiapoptotic protein FLIP
has been described extensively in many
cellular models (Thome and Tschopp,
2001), its function in the nervous system
has been poorly documented. Raoul et al.
(1999) have suggested that motoneurons
maintained in the presence of neurotro-
phins for 3 d became resistant to Fas
activation as a result of FasL downregula-
tion and FLIP upregulation. However, the
requirement of FLIP for gaining resistance to Fas was not further
investigated in that model. Conversely, Wu et al. (2004) reported
that FLIP-L can prevent Fas-mediated but not NGF withdrawal-
induced cell death in PC12 cells. These observations support
the differential responses we observed concerning the
antiapoptotic function of FLIP-L in the different neuronal pop-
ulations we studied. It might be speculated that regulation of
caspase activity could be differential between cellular compart-
ments. Ivins et al. (1998) showed that hippocampal neurons
treated with -amyloid display localized caspase activation lead-
ing to neurite degeneration, although the death signals may not
affect cell viability. According to our findings, it would be of
interest to study whether FLIP-L might act locally as an inhib-
itor of caspase-8 protecting from local neurite degeneration,
or rather as a proneuritogenic factor, in that model of com-
partmented neuronal cultures.
To avoid uncontrolled cell and tissue damage, apoptosis is
tightly controlled by inhibitors, including the DR antagonists.
Notably in the nervous system, recent advances have been made
concerning the role of FAIM and Lifeguard (FAIM2) in the an-
tagonismof apoptosis induced by FasL or tumor necrosis factor
(TNF) (Sole et al., 2004; Ferna´ndez et al., 2007; Segura et al.,
2007). Particularly, we have demonstrated that the two splice
variants of FAIM [the long form of FAIM (FAIM-L) and
FAIM-S] display diverse functions in the nervous system.
Whereas FAIM-L blocks Fas and TNF-induced apoptosis in
Figure 7. A, PC12 cells were infected with lentiviral particles containing the sequence of an RNAi against FLIP-L (RNAi) or a
scrambled sequence (Scr). After 3 d, total extracts were probed with anti-FLIP (Dave-2) antibody by Western blot, and the
membranewas reprobedwith anti-tubulin as a loading control.B, PC12 cells infectedwith FLIP-L RNAi or scrambled (Scr) lentiviral
particles were incubated or not with 100 ng/ml NGF for 5 d, and total neurite length was measured. Significant differences are
indicated (*p 0.001, t test). C, Representative images of NGF-induced differentiation of PC12 cells as described in B after 5 d of
treatment are shown. Scale bars, 100m. D, After 3 d of PC12 infection with lentiviral particles containing the sequence of the
RNAi against FLIP-L or a scrambled sequence (Scr), cells were serum starved for 12 h, then stimulated with 100 ng/ml NGF for the
indicated times. Protein (250 g) was immunoprecipitated using the anti-pan-Trk (-203) antibody, and the membrane was
blotted with the anti-phospho-Tyr (4G10) antibody. As input controls, lysates were blotted with anti-FLIP (Dave-2) to ensure
efficient knockdown and anti-TrkA. Lysates from the same experiment were analyzed by Western blot (WB) to assess the phos-
phorylation of ERK1/2. The membrane was stripped and reprobed with an anti-pan-ERK antibody to control protein loading.
E, After 2 d of infectionwith lentiviruses containing FLIP-L RNAi or scrambled sequences, PC12 cellswere plated in adequate plates
and transfectedwith an NF-B-dependent reporter vector (LTR KB). After 24 h, cells were serum starved for 12 h, then stimulated
for 5 h with 100 ng/ml NGF. Luciferase activity was measured in the cell lysates using a Luciferase Assay System (Promega).
Significant differences are indicated (*p 0.05, t test).
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differentiated PC12 cells, motoneurons, cortical neurons (Segura
et al., 2007), and dopaminergic neurons (Yu et al., 2008), FAIM-S
overexpression enhances neurite outgrowth in differentiated
PC12 cells and primary neurons, mainly through the activation
and modulation of the NF-B pathway (Sole et al., 2004). In
contrast to its established role in regulating cell survival in the
immune system, we revealed a novel role for FAIM-S in the con-
trol of neurite growth in the developing nervous system. FAIM-S
binds neurotrophin receptors TrkA and p75NTR during NGF
stimulation, thereby enhancing differentiation (Sole et al., 2004).
Similarities and differences can be drawn from the findings we
substantiated for FAIM and now for FLIP. First, both proteins
display a dual role in the nervous system. FAIM needs two splice
variants to achieve its different roles: FAIM-L is antiapoptotic,
whereas FAIM-S is pro-neuritogenic. However, the long form
of FLIP is able to perform a pro-differentiation role, as well as an
antiapoptotic function depending on
the cellular context. Second, FAIM-S
and FLIP-L both promote neurite out-
growth during NGF differentiation by
mechanisms depending on ERK (FLIP-L)
and NF-B activation (both FAIM-S and
FLIP-L). Finally, both FAIM-S and
FLIP-L interact with NGF receptors, only
in the presence of the neurotrophin.
However, whereas FAIM-S interacts with
both NGF receptors TrkA and p75NTR,
FLIP-L only interacts with TrkA or with
the TrkB receptor in whole-brain lysates
of E15 mice embryos. Therefore, we re-
port in the present work that FLIP-L is a
dual protein in both the nervous system
and, as reported previously, the immune
system.
It has been reported that both FLIP
and caspase-8 are necessary for survival
and proliferation of activated T lympho-
cytes. Elevated expression levels of FLIP
have a dual effect blocking the apoptotic
signaling cascade, on the one hand, and
stimulating signaling pathways that lead
to cellular proliferation, on the other hand
(Peter, 2004; Budd et al., 2006). However,
there has been no conclusive evidence that
FLIP mediates these two functions
through distinct molecular mechanisms
(Lens et al., 2002; Tai et al., 2004). It is
plausible that, after stimulation by neuro-
trophins, neurons would acquire a differ-
entiated phenotype as a survival strategy.
Additionally, neurons that would not at-
tain a neuronal phenotype suitable for
reaching the sources of trophic factors
would undergo apoptosis. Therefore,
FLIP-L might potentiate the survival of
the neuron, allowing for the time neces-
sary to reach its target. However, our re-
sults do not support this hypothesis
because the overexpression of FLIP-L
protects only motoneurons from neuro-
trophin deprivation. Moreover, in the
three neuronal models tested, the overex-
pression of FLIP-L promotes neurite out-
growth, regardless of whether it antagonizes neurotrophin
deprivation-induced apoptosis or not. Consequently, the pro-
neuritogenic function of FLIP-L seems to bemore general than its
antiapoptotic function, at least in the nervous system. Finally, the
reduction of the endogenous levels of FLIP-Lwas not toxic in any
of the cellular models studied, nor did it affect proliferation of
PC12 cells (data not shown). All these observations allow us to
confirm that we found a novel function for FLIP-L in the nervous
system, clearly separated from the antiapoptotic function it
might exert in a specific neuronal cell type.
In CD3-activated T lymphocytes, increased levels of FLIP-L
lead to the activation of the MAPK/ERK and NF-B signaling
pathways through the recruitment of TNF receptor-associated
factors 1 and 2, receptor-interacting protein, and Raf-1 (Kataoka
et al., 2000). Our findings go in the same direction because
knockdown of FLIP-L significantly reduced the phosphorylation
Figure8. A, HEK293T cellswere transfectedwith FAIM-S, FLIP-L, TrkA, or p75 taggedwith FLAGorHAas described in the figure.
After 48 h, NGF stimulationwas used in all conditions (100 ng/ml, 15min). FLAG-tagged FLIP-L and FAIM-Swere immunoprecipi-
tated using FLAG-specific mAb M2-coupled agarose beads (Sigma). The immunoprecipitates (eluted fractions) were resolved by
SDS-PAGE, and proteinswere transferred onto PVDFmembranes and immunoblottedwith HA antibody (top). A fraction of the cell
lysates was blotted with anti-FLAG or anti-HA as input controls (bottom). WB, Western blot. B, PC12 stably transfected with
pcDNA3–TrkA were infected with lentiviral particles containing FLIP-L–FLAG. At 24 h after infection, cells were serum starved for
12 h, then stimulated () or not () with 100 ng/ml NGF for 15 min. Lysates were performed and subjected to immunoprecipi-
tation using anti-pan-Trk-203 antibody, before immunoblotting with anti-TrkA and anti-FLIP (Dave-2) (top). A fraction of the
cell lysates was blotted with anti-TrkA and anti-FLIP (Dave-2) as input controls (bottom). C, PC12 cells stably transfected with
pcDNA3–TrkA were infected with lentiviral particles containing the FLIP-L–Flag () or the empty vector (). At 24 h after
infection, cells were serum starved for 12 h, then stimulated () or not () with 100 ng/ml NGF for 15 min. Lysates were
performed and subjected to immunoprecipitation as described in A and immunoblottedwith anti-TrkA (top). A fraction of the cell
lysates was blotted with anti-TrkA and anti-FLIP (Dave-2) (bottom). D, For the endogenous interaction of FLIP-L with TrkB in
whole-brain lysates, 2 mg of total protein were immunoprecipitated with anti-FLIP (Dave-2) and immunoblotted with anti-TrkB
(top) and anti-FLIP (Dave-2) (bottom). As control, a rat monoclonal antibody anti-HA (Rat IgG) was used.
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of ERK1/2 as well as NF-B activation. Indeed, we demonstrated
that both pathways are necessary for FLIP-L-mediated neurite
outgrowth. The inhibition of theMAPK/ERK or NF-B pathway
leads to a partial although significant inhibition, whereas when
MAPK/ERK and NF-B pathways are simultaneously blocked,
the neurite outgrowth is totally abrogated, regardless of FLIP-L
expression levels. Then, FLIP-L requires both MAPK/ERK and
NF-B pathway to enhance NGF-induced neuritogenesis.
Although NGF is the ligand of both TrkA and p75NTR, coim-
munoprecipitation experiments demonstrated that FLIP-L is
able to interact only with TrkA in an NGF-dependent manner. It
has also been documented that, although both NGF receptors
independently activate the NF-B pathway (Foehr et al.,
2000a,b), the main stimulus is initiated by p75NTR, with TrkA
exerting a slightly inhibiting effect (Mamidipudi et al., 2002). So
far, FLIP has always been linked to the DISC complex, which is
formed during activation of the DRs. However, our results show
that, at least in the nervous system, FLIP-L could be part of an-
other multiprotein complex that is not necessarily composed by
DISCmembers. First, the activation stimulus of our models does
not implicate any DR but rather engages neurotrophin receptors
TrkB, TrkA, and p75NTR that promote neuronal survival and
neurite growth. Second, the interaction of FLIP-L and TrkA is
dependent on the NGF stimulus. However, these coimmunopre-
cipitation experiments should be cautiously interpreted because
the interactionmight be indirect. In any case, the activation of the
TrkA receptor promotes the formation of a novel complex in
which FLIP-L is included. Moreover, this protein is relevant for
the correct activation of the MAPK/ERK and NF-B, pathways
triggered during TrkA ligation, because FLIP-L downregulation
drastically affects the activation of both pathways. The p75NTR
receptor seems not to be implicated in FLIP-L-mediated signal-
ing, but we should not exclude that it might be modulated by
FLIP-L, although in an indirect way.
We provide evidence that, although cell death, survival, pro-
liferation, and differentiation/growth processes are finely regu-
lated, the frontier between two opposite cellular processes (i.e.,
apoptosis/neurite growth) can be tenuous. In other words, they
can be controlled by the samemolecule(s). In that sense, it might
be envisioned that the specific function of a given protein might
depend on the intracellularmolecular environment, as well as the
spatiotemporal conditions. It has been established in the immune
system that FLIP-L acts as amultifunctional protein that switches
off DR-activated signaling pathways by either blocking caspase-8
activation or recruiting adaptor proteins and kinases that initiate
pathways leading to proliferation or differentiation (Kataoka et
al., 2000). In the nervous system, FLIP-L promotes neurite out-
growth but acts as an antiapoptotic protein in certain cellular
models (i.e., motoneurons). Most interestingly, the expression
pattern of FLIP-L during the embryonic development or inNGF-
induced differentiation of PC12 cells, as well as its tissular expres-
sion pattern inmouse brain, further supports its novel role in the
nervous system. At E16, the peak of expression of FLIP-L in the
brain cortex is neuronal, whereas the distribution and morphol-
ogy of FLIP-positive cells corresponds with glial-like cells at later
stages. We might hypothesize that, early at E16, FLIP-L plays a
pro-differentiation role in the cortex, allowing neurite outgrowth
and branching processes, redistributing at later stages to the glia,
in which it can participate in antagonizing apoptosis induced by
death ligands (i.e., TNF or FasL). These ligands can be produced
by microglia or astrocytes in certain pathological situations such
as cerebral ischemia (Kaushal and Schlichter, 2008). Nonetheless,
the characterization of the role of FLIP in glial or microglial
cells requires additional experimental work. In summary, we
have uncovered a new unexpected role for FLIP-L, a death
receptor antagonist, as a crucial factor in neurotrophin-
induced neurite growth capable of interacting with TrkB or
TrkA in a neurotrophin-dependent manner.
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